XML 10 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 135,178 $ 193,198
Accounts receivable 163,714 193,094
Prepaid expenses and other assets 49,564 50,530
Income taxes refundable 35,399 35,399
Loan receivable from Emergence Global Enterprises Inc. - related party 0 0
Total current assets 383,855 472,221
Other assets    
Operating lease right-of-use assets 125,167 138,103
Other receivable 79,296 0
Note receivable - CEN Biotech Ukraine LLC - related party 44,859 44,859
Advances to CEN Biotech Ukraine LLC - related party 1,299,328 1,299,328
Property and equipment, net 87,454 97,403
Deferred income taxes (2,720) (2,720)
Intangible assets, net (4,988,125) (5,072,031)
Goodwill 1,314,134 1,314,134
Total assets 8,324,938 8,440,799
Current liabilities    
Accounts payable 444,405 440,332
Accounts payable – related parties 31,837 101,422
Loans payable 1,688,793 1,688,793
Loans payable – related parties 2,701,641 2,701,641
Convertible notes payable, net of unamortized discount 643,330 643,330
Convertible notes payable, net of unamortized discount - related parties 162,639 162,639
Accrued interest 1,396,563 1,361,689
Accrued interest – related parties 1,962,816 1,873,455
Operating lease liabilities 114,976 103,908
Governmental assistance payable 145,333 145,333
Accrued expenses 714,115 638,073
Total current liabilities 10,006,448 9,860,615
Operating lease liabilities, less current portion 188,090 206,763
CEBA loan payable 47,400 31,552
Total liabilities 10,241,938 10,098,930
Commitments and contingencies (Notes 4, 11, 12, 18, 19, 24, and 25)
Shareholders’ deficit    
Common stock; unlimited authorized shares; 55,597,743 and 55,597,743 issued and outstanding as of March 31, 2022, and December 31, 2021, respectively. No par value. 0 0
Additional paid-in capital 44,339,973 44,339,973
Accumulated deficit (46,221,218) (45,964,183)
Accumulated other comprehensive loss (35,755) (33,921)
Total shareholders’ deficit (1,917,000) (1,658,131)
Total liabilities and shareholders’ deficit $ 8,324,938 $ 8,440,799